We are live on ! Find out more

503 hedge funds and large institutions have $12.5B invested in Sanofi in 2015 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 174 increasing their positions, 173 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $33.6M | Put options by funds: $20.1M

8% more funds holding in top 10

Funds holding in top 10: 1314 (+1)

1% more repeat investments, than reductions

Existing positions increased: 174 | Existing positions reduced: 173

0.31% less ownership

Funds ownership: 19.64%19.34% (-0.31%)

3% less capital invested

Capital invested by funds: $12.9B → $12.5B (-$323M)

3% less funds holding

Funds holding: 518503 (-15)

19% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 47

Holders
503
Holders Change
-15
Holders Change %
-2.9%
% of All Funds
13.49%
Holding in Top 10
14
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+7.69%
% of All Funds
0.38%
New
38
Increased
174
Reduced
173
Closed
47
Calls
$33.6M
Puts
$20.1M
Net Calls
+$13.5M
Net Calls Change
-$11M

SNY Hedge Fund Activity: Q2 2015 in Review

503 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2015, worth a combined $12.5B — down 2.5% from $12.9B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of SNY and 38 opened new positions — a net loss of 9 holders — while 173 trimmed existing stakes and 174 added.

The largest buyer was Dodge & Cox, adding an estimated $341M. The largest seller was Neuberger Berman Group, cutting an estimated $187M.

  • 503 institutional investors held Sanofi (SNY) as of Q2 2015, down from 518 in Q1 2015.
  • Funds reported $12.5B of Sanofi stock for Q2 2015, down 2.5% quarter-over-quarter.
  • 38 funds opened new Sanofi positions in Q2 2015 and 47 closed out, a net change of -9 holders.
  • The largest Sanofi buyer in Q2 2015 was Dodge & Cox, an estimated $341M added.
  • The largest Sanofi seller in Q2 2015 was Neuberger Berman Group, an estimated $187M sold.

Based on aggregated 13F filings for Q2 2015.